Supplementary Figure 4 from First Evidence of Sphingosine 1-Phosphate Lyase Protein Expression and Activity Downregulation in Human Neoplasm: Implication for Resistance to Therapeutics in Prostate Cancer

Authors :: Olivier Cuvillier
Bernard Malavaud
Magalie Bocquet
Catherine Mazerolles
Isabelle Ader
Leyre Brizuela
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file, 78K, S1P degradation products do not sensitize to radiotherapy or chemotherapy in PC-3 and C4-2B prostate cancer cells.

Full Text Access

Tools